BackTable Urology
Ep. 193 Bladder Cancer Innovations: ESMO 2024 Highlights with Dr. Andrea Apolo
Dr. Andrea Apolo
The question that I think comes up is what is the role now of adjuvant immunotherapy now that we have the Niagara data, right? So how does that fit in? I mean, if everyone's going to be getting Dervalium-AV plus Gem-Sys in the neoadjuvant setting,
0
💬
0
Comments
Log in to comment.
There are no comments yet.